Human HVEM/TNFRSF14 Antibody, R&D Systems™

HVEM/TNFRSF14

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

ATAR, CD270, CD270 antigen, CD40-like protein, Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA, HVEMTR2HVEAATAR, LIGHTR, TNFRSF14, tumor necrosis factor receptor superfamily member 14, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entrymediator), Tumor necrosis factor receptor-like 2, tumor necrosis factor receptor-like gene2

Mouse

Protein A or G purified from ascites

RUO

8764

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot, Flow Cytometry, CyTOF, ELISA

94801

Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

AAB58354

TNFRSF14

Mouse myeloma cell line NS0-derived recombinant human HVEM/TNFRSF14 Pro37-Val202 (Ser108Thr and Ala140Arg) Accession # AAB58354

100 μg

Primary

Detects human HVEM/TNFRSF14 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant human (rh) CD30 and no cross-reactivity with rh4-1BB, rhCD27, rhCD40, rhDR3, rhDR6, rhFas, rhGITR, rhNGF-R, rhOPG, rhRANK, recombinant mouse (rm) RANK, rhTAJ, rhTNF RI, rhTNF RII, or rmTNF RI is observed.

Human

Ascites